Dystonia Drugs Market

• COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
• Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global dystonia drugs market. 

Top Impacting Factors

Increase in the prevalence rate of dystonia disorders worldwide and rise in demand for novel therapies act as the major factors driving the expansion of dystonia drug market. 

The growing awareness about dystonia therapy and technological advancement is driving the growth of the market.

Rise in investment in the research and development activities to reinforce the overall course of diagnosis and treatment of dystonia and developments in the treatment accelerate the dystonia drug market growth.

Additionally, public awareness about diseases and treatment options, improving healthcare infrastructure, increasing investment, and surge in healthcare expenditure positively affect the dystonia drug market. 

Furthermore, the growing adoption of deep brain stimulation for the treatment of intractable movement disorders has led to the emergence of pallidal stimulation as the surgical therapy of choice for many patients with dystonia, which acts as driver of the market.

However, the effective treatment is either unavailable or unaffordable & lack of knowledge about dystonia in some developing countries restrain the growth of the dystonia drugs market.

          
Market Trends
New Product Launches to Flourish the Market

• In October 2020,  Revance Therapeutics, Inc., a biotechnology company, announced positive results from its ASPEN-1 Phase 3 randomized, double-blind, clinical trial for its investigational drug candidate DaxibotulinumtoxinA for Injection for the treatment of cervical dystonia, a chronic and neurologic condition affecting the muscles of the neck.
• In 2020, Pfizer Inc. announced that the Phase 3 study evaluated the safety and efficacy of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in adults with moderate to severe atopic dermatitis who were also on background topical therapy.

Key Benefits of the Report

• This study presents the analytical depiction of the dystonia drugs market industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the dystonia drugs market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the dystonia drugs market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
• The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Dystonia Drugs Market Report

• Which are the leading market players active in the dystonia drugs market?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What future projections would help in taking further strategic steps?
• What is dystonia drugs market?
• What is dystonia drugs market prediction in the future?
• Who are the leading global players in dystonia drugs market?
• What are the current trends and predicted trends?
• What are the key benefits of the dystonia drugs market report?